Clinical outcomes of sorafenib treatment in patients with metastatic hepatocellular carcinoma who had been previously treated with fluoropyrimidine plus platinum-based chemotherapy. [electronic resource]
Producer: 20110602Description: 125-9 p. digitalISSN:- 1537-453X
- Adult
- Aged
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Benzenesulfonates -- adverse effects
- Capecitabine
- Carcinoma, Hepatocellular -- drug therapy
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Drug-Related Side Effects and Adverse Reactions
- Female
- Fluorouracil -- administration & dosage
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Metastasis
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Proportional Hazards Models
- Pyridines -- adverse effects
- Republic of Korea
- Retrospective Studies
- Risk Factors
- Sorafenib
- Survival Analysis
- Treatment Failure
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.